A randomized trial to assess the biological activity of short-term (pre-surgical) fulvestrant 500 mg plus anastrozole versus fulvestrant 500 mg alone or anastrozole alone on primary breast cancer
John F. R. Robertson(University of Nottingham), Julia M.W. Gee(Alberta Health Services)
Cited by 35